the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid.
.
.
.
classifieds
.
watch: secretary of state and sinn fein's martina anderson in row at balmoral show
.
marketwatch: "new migraine drugs have promise -- and a ,500 price tag."
.
loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people.
. severe psoriasis. credit: penn medicine
.